OraSure Technologies, Inc. (OSUR)
USD 3.79
(-2.07%)
USD 3.79
(-2.07%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 13.5 Million USD | 7.63% |
| 2022 | 12.54 Million USD | 2.22% |
| 2021 | 12.27 Million USD | 100.29% |
| 2020 | 6.12 Million USD | 9.86% |
| 2019 | 5.57 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | -100.0% |
| 2011 | 7.29 Million USD | -6.4% |
| 2010 | 7.79 Million USD | -6.15% |
| 2009 | 8.3 Million USD | -6.3% |
| 2008 | 8.85 Million USD | -5.49% |
| 2007 | 9.37 Million USD | -11.89% |
| 2006 | 10.63 Million USD | 693.63% |
| 2005 | 1.34 Million USD | -45.43% |
| 2004 | 2.45 Million USD | -31.43% |
| 2003 | 3.58 Million USD | -19.94% |
| 2002 | 4.47 Million USD | -3.63% |
| 2001 | 4.64 Million USD | -19.5% |
| 2000 | 5.76 Million USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | -100.0% |
| 1996 | 10.6 Million USD | 194.44% |
| 1995 | 3.6 Million USD | -12.2% |
| 1994 | 4.1 Million USD | -12.77% |
| 1993 | 4.7 Million USD | -14.55% |
| 1992 | 5.5 Million USD | 0.0% |
| 1991 | - USD | 0.0% |
| 1990 | - USD | -100.0% |
| 1989 | 200 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 12.62 Million USD | -2.82% |
| 2024 Q1 | 12.99 Million USD | -3.81% |
| 2023 Q2 | 15.42 Million USD | 27.63% |
| 2023 Q3 | 15.02 Million USD | -2.61% |
| 2023 Q4 | 13.5 Million USD | -10.11% |
| 2023 FY | 13.5 Million USD | 7.63% |
| 2023 Q1 | 12.08 Million USD | -3.68% |
| 2022 Q2 | 19.65 Million USD | 27.26% |
| 2022 Q3 | 18.6 Million USD | -5.35% |
| 2022 Q4 | 12.54 Million USD | -32.57% |
| 2022 Q1 | 15.44 Million USD | 25.86% |
| 2022 FY | 12.54 Million USD | 2.22% |
| 2021 FY | 12.27 Million USD | 100.29% |
| 2021 Q4 | 12.27 Million USD | -16.3% |
| 2021 Q3 | 14.66 Million USD | 13.34% |
| 2021 Q2 | 12.93 Million USD | 105.89% |
| 2021 Q1 | 6.28 Million USD | 2.55% |
| 2020 Q3 | 6.5 Million USD | -5.93% |
| 2020 Q2 | 6.91 Million USD | 2.13% |
| 2020 Q1 | 6.76 Million USD | 21.32% |
| 2020 FY | 6.12 Million USD | 9.86% |
| 2020 Q4 | 6.12 Million USD | -5.74% |
| 2019 FY | 5.57 Million USD | 0.0% |
| 2019 Q3 | 3.88 Million USD | -7.48% |
| 2019 Q4 | 5.57 Million USD | 43.69% |
| 2019 Q1 | 4.37 Million USD | 0.0% |
| 2019 Q2 | 4.19 Million USD | -4.09% |
| 2018 Q1 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q2 | 7.04 Million USD | -1.74% |
| 2012 Q3 | - USD | -100.0% |
| 2012 Q1 | 7.16 Million USD | -1.71% |
| 2012 FY | - USD | -100.0% |
| 2011 FY | 7.29 Million USD | -6.4% |
| 2011 Q3 | 7.41 Million USD | -1.66% |
| 2011 Q4 | 7.29 Million USD | -1.69% |
| 2011 Q1 | 7.66 Million USD | -1.6% |
| 2011 Q2 | 7.54 Million USD | -1.63% |
| 2010 Q1 | 8.16 Million USD | -1.62% |
| 2010 FY | 7.79 Million USD | -6.15% |
| 2010 Q4 | 7.79 Million USD | -1.58% |
| 2010 Q3 | 7.91 Million USD | -1.56% |
| 2010 Q2 | 8.04 Million USD | -1.53% |
| 2009 Q3 | 8.44 Million USD | -1.63% |
| 2009 Q1 | 8.71 Million USD | -1.57% |
| 2009 FY | 8.3 Million USD | -6.3% |
| 2009 Q4 | 8.3 Million USD | -1.65% |
| 2009 Q2 | 8.58 Million USD | -1.6% |
| 2008 Q1 | 9.27 Million USD | -1.04% |
| 2008 FY | 8.85 Million USD | -5.49% |
| 2008 Q2 | 9.13 Million USD | -1.5% |
| 2008 Q3 | 8.99 Million USD | -1.52% |
| 2008 Q4 | 8.85 Million USD | -1.55% |
| 2007 Q4 | 9.37 Million USD | -5.2% |
| 2007 FY | 9.37 Million USD | -11.89% |
| 2007 Q2 | 10.57 Million USD | -0.27% |
| 2007 Q1 | 10.6 Million USD | -0.33% |
| 2007 Q3 | 9.88 Million USD | -6.5% |
| 2006 FY | 10.63 Million USD | 693.63% |
| 2006 Q3 | 10.93 Million USD | -0.56% |
| 2006 Q1 | 1.06 Million USD | -20.69% |
| 2006 Q2 | 11 Million USD | 934.75% |
| 2006 Q4 | 10.63 Million USD | -2.74% |
| 2005 Q1 | 2.17 Million USD | -11.41% |
| 2005 FY | 1.34 Million USD | -45.43% |
| 2005 Q4 | 1.34 Million USD | -17.18% |
| 2005 Q3 | 1.61 Million USD | -14.69% |
| 2005 Q2 | 1.89 Million USD | -12.83% |
| 2004 FY | 2.45 Million USD | -31.43% |
| 2004 Q1 | 3.3 Million USD | -7.86% |
| 2004 Q3 | 2.73 Million USD | -9.33% |
| 2004 Q4 | 2.45 Million USD | -10.26% |
| 2004 Q2 | 3.01 Million USD | -8.54% |
| 2003 Q1 | 4.31 Million USD | -3.62% |
| 2003 Q3 | 3.86 Million USD | -6.78% |
| 2003 FY | 3.58 Million USD | -19.94% |
| 2003 Q2 | 4.14 Million USD | -3.89% |
| 2003 Q4 | 3.58 Million USD | -7.29% |
| 2002 Q3 | 4.48 Million USD | 8.19% |
| 2002 Q4 | 4.47 Million USD | -0.18% |
| 2002 Q1 | 4.34 Million USD | -6.38% |
| 2002 Q2 | 4.14 Million USD | -4.69% |
| 2002 FY | 4.47 Million USD | -3.63% |
| 2001 Q1 | 5.49 Million USD | -4.76% |
| 2001 Q2 | 5.21 Million USD | -5.07% |
| 2001 Q3 | 4.92 Million USD | -5.51% |
| 2001 Q4 | 4.64 Million USD | -5.77% |
| 2001 FY | 4.64 Million USD | -19.5% |
| 2000 Q2 | - USD | 0.0% |
| 2000 FY | 5.76 Million USD | 0.0% |
| 2000 Q4 | 5.76 Million USD | -5.28% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q3 | 6.09 Million USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 FY | - USD | -100.0% |
| 1997 Q1 | 200 Thousand USD | -96.55% |
| 1997 Q2 | - USD | -100.0% |
| 1997 Q4 | - USD | 0.0% |
| 1996 Q4 | 5.8 Million USD | -45.28% |
| 1996 Q1 | 3.6 Million USD | 0.0% |
| 1996 Q2 | 3.6 Million USD | 0.0% |
| 1996 Q3 | 10.6 Million USD | 194.44% |
| 1996 FY | 10.6 Million USD | 194.44% |
| 1995 Q1 | 3.6 Million USD | -12.2% |
| 1995 Q2 | 3.6 Million USD | 0.0% |
| 1995 Q3 | 3.6 Million USD | 0.0% |
| 1995 Q4 | 3.6 Million USD | 0.0% |
| 1995 FY | 3.6 Million USD | -12.2% |
| 1994 FY | 4.1 Million USD | -12.77% |
| 1994 Q4 | 4.1 Million USD | 0.0% |
| 1994 Q3 | 4.1 Million USD | 0.0% |
| 1994 Q2 | - USD | -100.0% |
| 1994 Q1 | 4.3 Million USD | -2.27% |
| 1993 FY | 4.7 Million USD | -14.55% |
| 1993 Q1 | 4.8 Million USD | 0.0% |
| 1993 Q2 | 4.7 Million USD | -2.08% |
| 1993 Q3 | 4.7 Million USD | 0.0% |
| 1993 Q4 | 4.4 Million USD | -6.38% |
| 1992 Q2 | - USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 FY | 5.5 Million USD | 0.0% |
| 1992 Q3 | 5.5 Million USD | 0.0% |
| 1992 Q4 | 4.8 Million USD | -12.73% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1990 Q2 | 100 Thousand USD | 0.0% |
| 1990 FY | - USD | -100.0% |
| 1990 Q3 | - USD | -100.0% |
| 1990 Q1 | 100 Thousand USD | -50.0% |
| 1990 Q4 | - USD | 0.0% |
| 1989 FY | 200 Thousand USD | 0.0% |
| 1989 Q4 | 200 Thousand USD | 0.0% |
| 1989 Q2 | 300 Thousand USD | 0.0% |
| 1989 Q3 | 200 Thousand USD | -33.33% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 85.7 Million USD | 84.244% |
| AngioDynamics, Inc. | 5.91 Million USD | -128.34% |
| AtriCure, Inc. | 74.49 Million USD | 81.872% |
| Avinger, Inc. | 15.39 Million USD | 12.283% |
| Azenta, Inc. | 60.43 Million USD | 77.656% |
| BioLife Solutions, Inc. | 42.69 Million USD | 68.368% |
| The Cooper Companies, Inc. | 2.56 Billion USD | 99.474% |
| Daxor Corporation | 755.65 Thousand USD | -1687.049% |
| Ekso Bionics Holdings, Inc. | 7.16 Million USD | -88.393% |
| Femasys Inc. | 6.7 Million USD | -101.526% |
| GlucoTrack, Inc. | 196 Thousand USD | -6789.796% |
| Harvard Bioscience, Inc. | 42.77 Million USD | 68.429% |
| Hologic, Inc. | 2.53 Billion USD | 99.467% |
| ICU Medical, Inc. | 1.7 Billion USD | 99.208% |
| Intuitive Surgical, Inc. | 89.8 Million USD | 84.962% |
| KORU Medical Systems, Inc. | 4.44 Million USD | -203.794% |
| LeMaitre Vascular, Inc. | 19.09 Million USD | 29.28% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 970 Million USD | 98.608% |
| Microbot Medical Inc. | 231 Thousand USD | -5745.887% |
| Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | -84.201% |
| Merit Medical Systems, Inc. | 891.35 Million USD | 98.485% |
| Nephros, Inc. | 1.83 Million USD | -635.512% |
| NovoCure Limited | 596.24 Million USD | 97.735% |
| NEXGEL, Inc. | 2.79 Million USD | -382.63% |
| NEXGEL, Inc. | 2.79 Million USD | -382.63% |
| Singular Genomics Systems, Inc. | 75.28 Million USD | 82.064% |
| Pro-Dex, Inc. | 13.54 Million USD | 0.317% |
| Pulse Biosciences, Inc. | 9.14 Million USD | -47.682% |
| Predictive Oncology Inc. | 2.85 Million USD | -372.694% |
| Precision Optics Corporation, Inc. | 3.43 Million USD | -293.191% |
| QuidelOrtho Corporation | 2.61 Billion USD | 99.483% |
| Repligen Corporation | 711.8 Million USD | 98.103% |
| Sanara MedTech Inc. | 11.79 Million USD | -14.517% |
| STAAR Surgical Company | 35.83 Million USD | 62.315% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 342 Thousand USD | -3848.538% |
| DENTSPLY SIRONA Inc. | 2.29 Billion USD | 99.413% |
| Jin Medical International Ltd. | 4.11 Million USD | -228.325% |